Date published: 2026-6-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

3-Morpholinosydnonimine (CAS 16142-27-1)

5.0(1)
Write a reviewAsk a question

See product citations (10)

Alternate Names:
3-Morpholinosydnonimine is also known as SIN-1.
Application:
3-Morpholinosydnonimine is a potent vasodilator that inhibits platelet aggregation and cysteine proteases.
CAS Number:
16142-27-1
Purity:
≥98%
Molecular Weight:
206.63
Molecular Formula:
C6H10N4O2•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

3-Morpholinosydnonimine (SIN-1) is a metabolite of molsidomine (sc-200337) which may act to decompose spontaneously in solution in the presence of oxygen. This reaction with 3-Morpholinosydnonimine releases nitric oxide (NO) and a superoxide anion, which under physiological conditions, reacts to produce peroxynitrite. 3-Morpholinosydnonimine is a potent vasodilator, inhibitor of platelet aggregation, general cysteine protease inhibitor. 3-Morpholinosydnonimine may act to produce significant protective effects in myocardial ischemia-reperfusion. Some of the effects of 3-Morpholinosydnonimine can be attenuated by nitroglycerin-induced tolerance.


3-Morpholinosydnonimine (CAS 16142-27-1) References

  1. Inhibition of cysteine protease activity by NO-donors.  |  Ascenzi, P., et al. 2001. Curr Protein Pept Sci. 2: 137-53. PMID: 12370021
  2. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.  |  Sharma, SK. and Ebadi, M. 2003. Antioxid Redox Signal. 5: 251-64. PMID: 12880480
  3. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide.  |  Hogg, N., et al. 1992. Biochem J. 281 (Pt 2): 419-24. PMID: 1310595
  4. Protective effect of 1-methylated beta-carbolines against 3-morpholinosydnonimine-induced mitochondrial damage and cell viability loss in PC12 cells.  |  Choi, WT., et al. 2004. Neurochem Res. 29: 1807-16. PMID: 15532535
  5. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.  |  Siegfried, MR., et al. 1992. J Pharmacol Exp Ther. 260: 668-75. PMID: 1738117
  6. The peroxynitrite donor 3-morpholinosydnonimine induces reversible changes in electrophysiological properties of neurons of the guinea-pig spinal cord.  |  Ashki, N., et al. 2008. Neuroscience. 156: 107-17. PMID: 18662749
  7. 3-morpholinosydnonimine participates in the attenuation of neointima formation via inhibition of annexin A2-mediated vascular smooth muscle cell migration.  |  Won, KJ., et al. 2011. Proteomics. 11: 193-201. PMID: 21204247
  8. The peroxynitrite donor 3-morpholinosydnonimine activates Nrf2 and the UPR leading to a cytoprotective response in endothelial cells.  |  Mattart, L., et al. 2012. Cell Signal. 24: 199-213. PMID: 21945407
  9. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.  |  Henry, PJ., et al. 1989. J Pharmacol Exp Ther. 248: 762-8. PMID: 2563771
  10. 3-morpholinosydnonimine (SIN-1)-induced oxidative stress leads to necrosis in hypertrophic chondrocytes in vitro.  |  He, Y., et al. 2018. Biomed Pharmacother. 106: 1696-1704. PMID: 30119244
  11. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.  |  Nishikawa, M., et al. 1982. J Pharmacol Exp Ther. 220: 183-90. PMID: 6118429
  12. Increased cytotoxicity of 3-morpholinosydnonimine to HepG2 cells in the presence of superoxide dismutase. Role of hydrogen peroxide and iron.  |  Gergel, D., et al. 1995. J Biol Chem. 270: 20922-9. PMID: 7673115
  13. Spin-trapping studies of peroxynitrite decomposition and of 3-morpholinosydnonimine N-ethylcarbamide autooxidation: direct evidence for metal-independent formation of free radical intermediates.  |  Augusto, O., et al. 1994. Arch Biochem Biophys. 310: 118-25. PMID: 8161194
  14. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.  |  Lipton, SA., et al. 1993. Nature. 364: 626-32. PMID: 8394509
  15. Activation of soluble guanylyl cyclase by the nitrovasodilator 3-morpholinosydnonimine involves formation of S-nitrosoglutathione.  |  Schrammel, A., et al. 1998. Mol Pharmacol. 54: 207-12. PMID: 9658207

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

3-Morpholinosydnonimine, 20 mg

sc-200339
20 mg
$89.00

3-Morpholinosydnonimine, 100 mg

sc-200339A
100 mg
$369.00